Back to Search Start Over

EBF: reflection on bioanalytical assay requirements used to support liquid microsampling

Authors :
Stephen White
Lieve Dillen
Zoe Cobb
Timothy Sangster
Neil Spooner
Glen Hawthorne
Karen Woods
Philip Timmerman
Source :
Bioanalysis. 6(19)
Publication Year :
2014

Abstract

Further to the discussions on the bioanalysis of samples generated using microsampling techniques [1–6] and more specifically the ongoing work of the European Bioanalysis Forum (EBF) Liquid Microsampling Consortium [7], this article seeks to highlight some of the ‘philosophical’ aspects around liquid microsampling and to introduce some of the experimental elements that will form part of future efforts by the Consortium. Discussion will be focused on three major areas: sample manipulation, homogeneity of samples and validation of assays. The scope of this manuscript will be liquid microsampling and will not focus on adsorption techniques such as dried blood spots (DBS) and solid phase microextraction. Different microsampling techniques have created great interest from toxicokinetic (TK) and pharmacokinetic (PK) scientists, since they offer the potential to reduce sample volumes for exposure assessment in biofluids. For preclinical studies microsampling can facilitate the generation of serial profiles in rodent exposure evaluation studies, rather than working with composite designs. Microsampling has facilitated the removal of satellite animal groups leading to substantial reductions in the number of animals required and the reduction or elimination of rodent warming. Benefits in the clinical environment include the ability to take reduced sample volumes from pediatric, elderly and critically ill patient populations. In a recent publication the NC3R group proposes the following definition of a blood microsample: the sample should ideally not contain more than 50 μl whole blood [8]. As a consequence the subsequent plasma volumes are 20 μl or lower. Another, more philosophical consideration would be the impact of sampling volume on the animal or subject; for example, 50 μl of blood may not be considered as a ‘microsample’ in the context of juvenile animals or newborn babies. Two major liquid microsampling approaches can be envisaged

Details

ISSN :
17576199
Volume :
6
Issue :
19
Database :
OpenAIRE
Journal :
Bioanalysis
Accession number :
edsair.doi.dedup.....ad7fa419978341477aa654545b2eb3f7